1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals – an observational cross-sectional study
- Contribution to journal › Article
- 2024
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
- Contribution to journal › Article
-
Mark
Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function
- Contribution to journal › Article
- 2023
-
Mark
Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population
- Contribution to journal › Article
-
Mark
Statin Treatment Intensity, Discontinuation, and Long-Term Outcome in Patients with Acute Myocardial Infarction and Impaired Kidney Function
- Contribution to journal › Article
-
Mark
Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial
- Contribution to journal › Article
-
Mark
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function
- Contribution to journal › Article
- 2020
-
Mark
Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction : A simulation study
- Contribution to journal › Article
- 2015
-
Mark
Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular Disease.
- Contribution to journal › Article
